Chemours Investors Have Until December 7 to File Securities Fraud Class Action
Nov 6, 2026
Chemours faces a securities fraud class action alleging misrepresentation of Opteon product demand following an 18.63% stock drop. Investors have until December 7, 2026, to apply as lead plaintiff in the case.
Show all 47 updates